UCB Stock CINNOBER BOAT
Stocks
0NZT
BE0003739530
Pharmaceuticals
OTC Markets Traded| Market Cap | 49.87B 56.95B 46.04B 42.96B 80.84B 5,393B 82.34B 552B 214B 2,659B 214B 209B 9,261B | P/E 2026 * |
28.2x | P/E 2027 * | 22x |
|---|---|---|---|---|---|
| Enterprise Value | 48.95B 55.9B 45.18B 42.16B 79.34B 5,293B 80.82B 542B 210B 2,610B 210B 205B 9,089B | EV / Sales 2026 * |
5.74x | EV / Sales 2027 * | 4.88x |
| Free-Float |
61.59% | Yield 2026 * |
0.56% | Yield 2027 * | 0.57% |
Last Transcript: UCB
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/01/2015 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 01/07/2020 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/01/2012 | |
| Director/Board Member | 67 | 01/01/2015 | |
| Director/Board Member | 56 | 24/04/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 57.29B | |
| -1.31% | +1.80% | +19.68% | -11.98% | 64.28B | |
| -3.94% | +39.10% | +39.10% | +39.10% | 43.45B | |
| -0.56% | +1.65% | -51.04% | -58.77% | 38.02B | |
| -0.26% | +8.19% | +71.37% | -23.42% | 31.98B | |
| +0.47% | +18.00% | +157.84% | -42.65% | 27.66B | |
| -1.13% | +9.36% | +65.80% | +83.28% | 22.91B | |
| -0.56% | +5.64% | +2.91% | +174.96% | 17.74B | |
| -0.13% | +3.87% | +62.33% | +122.76% | 16.45B | |
| +3.43% | +8.07% | +66.03% | +338.38% | 14.1B | |
| Average | -0.47% | +6.92% | +48.23% | +69.07% | 30.73B | |
| Weighted average by Cap. | -0.84% | +6.00% | +40.44% | +30.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.53B 9.74B 7.88B 7.35B 13.83B 923B 14.09B 94.46B 36.67B 455B 36.62B 35.79B 1,585B | 9.63B 10.99B 8.89B 8.29B 15.6B 1,041B 15.89B 107B 41.36B 513B 41.31B 40.38B 1,787B |
| Net income | 1.75B 1.99B 1.61B 1.5B 2.83B 189B 2.88B 19.33B 7.5B 93.13B 7.49B 7.33B 324B | 2.29B 2.61B 2.11B 1.97B 3.71B 247B 3.77B 25.31B 9.82B 122B 9.81B 9.59B 425B |
| Net Debt | -925M -1.06B -854M -797M -1.5B -100B -1.53B -10.24B -3.97B -49.33B -3.97B -3.88B -172B | -2.93B -3.35B -2.71B -2.53B -4.75B -317B -4.84B -32.46B -12.6B -156B -12.58B -12.3B -544B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
